Our AI writing assistant, WriteUp, can assist you in easily writing any text. Click here to experience its capabilities.

Regions

Summary

The article discusses the launch of Primasun, a joint venture between Alphabet's Verily and ResMed. The platform is designed to help employers and healthcare providers identify populations at risk for complex sleep disorders. Initially, Primasun will evaluate patients with insomnia and provide guidance to improve sleep hygiene. The companies hope that the platform will generate greater awareness about the importance of sleep and help pave more equitable pathways for people to optimize their sleep and overall health.

Q&As

What is the Primasun platform?
The Primasun platform is an end-to-end solution to help employers and healthcare providers identify populations at risk for complex sleep disorders.

What are the goals of Primasun?
The goals of Primasun are to initially evaluate patients with insomnia, provide guidance to improve sleep hygiene and connect patients with certified sleep physicians who diagnose and treat sleep apnea.

How will the platform be used to help patients with sleep disorders?
The platform will be used to help patients with sleep disorders by evaluating them, providing guidance on how to improve their sleep hygiene, and connecting them with certified sleep physicians.

What is the evidence that sleep disorders can have negative effects on health?
The evidence that sleep disorders can have negative effects on health comes from the CDC, which has linked lack of sleep with chronic conditions such as heart disease, depression, diabetes, and heart disease.

What is the relationship between Verily and ResMed?
The relationship between Verily and ResMed is that they are joint venture partners in Primasun.

AI Comments

👍 "The clinical proof is clear: Diagnosing and treating sleep disorders can help people live healthier and longer, be safer and more present in their work and personal lives, and lower their healthcare costs," Carlos M. Nunez, M.D., chief medical officer of ResMed and Primasun board member, said in a statement.

👎 A third of U.S. adults report getting less than the recommended amount of sleep, and lack of rest has been linked with chronic conditions such as heart disease, depression, diabetes and heart disease, according to the CDC.

AI Discussion

Me: It's about a new joint venture between ResMed and Verily called Primasun. The aim is to help employers and healthcare providers identify populations at risk for complex sleep disorders.

Friend: That's interesting. I didn't know that sleep disorders could be that complex.

Me: Yeah, I didn't either. But apparently, they can be linked with chronic conditions like heart disease, depression, and diabetes.

Friend: That makes sense. I know that lack of sleep can definitely make me feel more stressed and anxious.

Me: Exactly. So, this platform will help patients with insomnia, and connect them with certified sleep physicians who can diagnose and treat sleep apnea.

Friend: That sounds like it could be really helpful for people. I'm glad they're doing this.

Action items

Technical terms

Alphabet's Verily
a life science offshoot of Alphabet, a holding company that owns Google
ResMed
a connected sleep device maker
Primasun
a joint venture between Verily and ResMed to help employers and healthcare providers identify populations at risk for complex sleep disorders
HLTH 2022
a conference in Las Vegas
CDC
the Centers for Disease Control and Prevention
AI
artificial intelligence

Similar articles

0.82823205 Epic rolls out app market replacement

0.8281727 Epic rolls out app market replacement

0.81847584 Samsung Electronics Unveils Samsung Health Stack 1.0

0.81443423 India orders Riemann Labs, linked to cough syrup deaths in Cameroon, to stop manufacturing

0.81283677 Business

🗳️ Do you like the summary? Please join our survey and vote on new features!